Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity
The double origin of carbon monoxide (CO) as an atmospheric pollutant or as an endogenous gaseous modulator of many pathophysiological processes prompted us to review some aspects of the bad side and of the good side of coin among the pleiotropic effects of CO. On the bad side of the coin, we focus...
Gespeichert in:
Veröffentlicht in: | Inflammation research 2006-07, Vol.55 (7), p.261-273 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 273 |
---|---|
container_issue | 7 |
container_start_page | 261 |
container_title | Inflammation research |
container_volume | 55 |
creator | Mannaioni, P F Vannacci, A Masini, E |
description | The double origin of carbon monoxide (CO) as an atmospheric pollutant or as an endogenous gaseous modulator of many pathophysiological processes prompted us to review some aspects of the bad side and of the good side of coin among the pleiotropic effects of CO. On the bad side of the coin, we focus on the interval form in acute CO poisoning, discussing experimental evidence suggesting that the delayed neuropathology after CO poisoning is a free radical-driven event. In this context, we challenge the mandatory place of hyperbaric oxygen therapy (HBO) in CO poisoning as a possible summation of oxy-radicals generated by HBO and the free radical cascade set in motion during the reoxygenation phase of acute CO-poisoning. We also discuss an opposing view, which provides evidence suggesting that HBO therapy actually decreases the load of free radicals in acute CO-poisoning and may be beneficial in preventing delayed neuropsychiatric sequelae.On the good side of the coin, we briefly outline the endogenous generation of CO and the leading role of heme-oxygenases (HO) in relation to the place of CO in biology and medicine. The main focus of this section is on the growing literature on CO and inflammation. Here we report on in-vitro and in-vivo studies on the modulation afforded by exogenously administered/endogenously produced CO in a variety of experimental and clinical settings of inflammation. Our recent studies on experimental models of allergic inflammation are also discussed, and the CO-releasing molecules envisaged as potential anti-inflammatory drugs suitable for clinical use. |
doi_str_mv | 10.1007/s00011-006-0084-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_216240444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1124432021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-96c9d820ceb08bf4c2cf6163438d3f097378c2ca521401d08964d254260a8b123</originalsourceid><addsrcrecordid>eNpFkFtLAzEQhYMotlZ_gC8SfHZ1ctlt1jcp3qDgi4JvIZuL3dLd1CQV99-bXsCHYYaZcw7Dh9AlgVsCML2LAEBIAVDlErwYjtCYcApFDeLzOM9AWcEEgxE6i3GZ1YIKeopGpKrLkgkxRu1Mhcb3uPO9_22NvcdpYXGjDFa92c1f3hsc8wl7t1to3_Y32AXf4d5ugu_VChur0gInn12pLdrerVTXqeTDgJVO7U-bhnN04tQq2otDn6CPp8f32Usxf3t-nT3MC81ZmYq60rURFLRtQDSOa6pdRSrGmTDMQT1lU5F3qqSEAzEg6oobWnJagRINoWyCrve56-C_NzYmufSbkJ-MkpKKcuCcZxHZi3TwMQbr5Dq0nQqDJCC3bOWercxs5ZatHLLn6hC8aTpr_h0HmOwPTkdz_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216240444</pqid></control><display><type>article</type><title>Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Mannaioni, P F ; Vannacci, A ; Masini, E</creator><creatorcontrib>Mannaioni, P F ; Vannacci, A ; Masini, E</creatorcontrib><description>The double origin of carbon monoxide (CO) as an atmospheric pollutant or as an endogenous gaseous modulator of many pathophysiological processes prompted us to review some aspects of the bad side and of the good side of coin among the pleiotropic effects of CO. On the bad side of the coin, we focus on the interval form in acute CO poisoning, discussing experimental evidence suggesting that the delayed neuropathology after CO poisoning is a free radical-driven event. In this context, we challenge the mandatory place of hyperbaric oxygen therapy (HBO) in CO poisoning as a possible summation of oxy-radicals generated by HBO and the free radical cascade set in motion during the reoxygenation phase of acute CO-poisoning. We also discuss an opposing view, which provides evidence suggesting that HBO therapy actually decreases the load of free radicals in acute CO-poisoning and may be beneficial in preventing delayed neuropsychiatric sequelae.On the good side of the coin, we briefly outline the endogenous generation of CO and the leading role of heme-oxygenases (HO) in relation to the place of CO in biology and medicine. The main focus of this section is on the growing literature on CO and inflammation. Here we report on in-vitro and in-vivo studies on the modulation afforded by exogenously administered/endogenously produced CO in a variety of experimental and clinical settings of inflammation. Our recent studies on experimental models of allergic inflammation are also discussed, and the CO-releasing molecules envisaged as potential anti-inflammatory drugs suitable for clinical use.</description><identifier>ISSN: 1023-3830</identifier><identifier>EISSN: 1420-908X</identifier><identifier>DOI: 10.1007/s00011-006-0084-y</identifier><identifier>PMID: 16955388</identifier><language>eng</language><publisher>Switzerland: Springer Nature B.V</publisher><subject>Animals ; Anti-Inflammatory Agents - pharmacology ; Carbon Monoxide - pharmacology ; Carbon Monoxide - toxicity ; Carbon Monoxide Poisoning ; Cell Death ; Heme Oxygenase (Decyclizing) - metabolism ; Humans ; Hyperbaric Oxygenation ; Inflammation - pathology ; Models, Biological ; Neurons - drug effects ; Neurons - pathology</subject><ispartof>Inflammation research, 2006-07, Vol.55 (7), p.261-273</ispartof><rights>Birkhäuser Verlag, Basel 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-96c9d820ceb08bf4c2cf6163438d3f097378c2ca521401d08964d254260a8b123</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16955388$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mannaioni, P F</creatorcontrib><creatorcontrib>Vannacci, A</creatorcontrib><creatorcontrib>Masini, E</creatorcontrib><title>Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity</title><title>Inflammation research</title><addtitle>Inflamm Res</addtitle><description>The double origin of carbon monoxide (CO) as an atmospheric pollutant or as an endogenous gaseous modulator of many pathophysiological processes prompted us to review some aspects of the bad side and of the good side of coin among the pleiotropic effects of CO. On the bad side of the coin, we focus on the interval form in acute CO poisoning, discussing experimental evidence suggesting that the delayed neuropathology after CO poisoning is a free radical-driven event. In this context, we challenge the mandatory place of hyperbaric oxygen therapy (HBO) in CO poisoning as a possible summation of oxy-radicals generated by HBO and the free radical cascade set in motion during the reoxygenation phase of acute CO-poisoning. We also discuss an opposing view, which provides evidence suggesting that HBO therapy actually decreases the load of free radicals in acute CO-poisoning and may be beneficial in preventing delayed neuropsychiatric sequelae.On the good side of the coin, we briefly outline the endogenous generation of CO and the leading role of heme-oxygenases (HO) in relation to the place of CO in biology and medicine. The main focus of this section is on the growing literature on CO and inflammation. Here we report on in-vitro and in-vivo studies on the modulation afforded by exogenously administered/endogenously produced CO in a variety of experimental and clinical settings of inflammation. Our recent studies on experimental models of allergic inflammation are also discussed, and the CO-releasing molecules envisaged as potential anti-inflammatory drugs suitable for clinical use.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Carbon Monoxide - pharmacology</subject><subject>Carbon Monoxide - toxicity</subject><subject>Carbon Monoxide Poisoning</subject><subject>Cell Death</subject><subject>Heme Oxygenase (Decyclizing) - metabolism</subject><subject>Humans</subject><subject>Hyperbaric Oxygenation</subject><subject>Inflammation - pathology</subject><subject>Models, Biological</subject><subject>Neurons - drug effects</subject><subject>Neurons - pathology</subject><issn>1023-3830</issn><issn>1420-908X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkFtLAzEQhYMotlZ_gC8SfHZ1ctlt1jcp3qDgi4JvIZuL3dLd1CQV99-bXsCHYYaZcw7Dh9AlgVsCML2LAEBIAVDlErwYjtCYcApFDeLzOM9AWcEEgxE6i3GZ1YIKeopGpKrLkgkxRu1Mhcb3uPO9_22NvcdpYXGjDFa92c1f3hsc8wl7t1to3_Y32AXf4d5ugu_VChur0gInn12pLdrerVTXqeTDgJVO7U-bhnN04tQq2otDn6CPp8f32Usxf3t-nT3MC81ZmYq60rURFLRtQDSOa6pdRSrGmTDMQT1lU5F3qqSEAzEg6oobWnJagRINoWyCrve56-C_NzYmufSbkJ-MkpKKcuCcZxHZi3TwMQbr5Dq0nQqDJCC3bOWercxs5ZatHLLn6hC8aTpr_h0HmOwPTkdz_Q</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Mannaioni, P F</creator><creator>Vannacci, A</creator><creator>Masini, E</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>200607</creationdate><title>Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity</title><author>Mannaioni, P F ; Vannacci, A ; Masini, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-96c9d820ceb08bf4c2cf6163438d3f097378c2ca521401d08964d254260a8b123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Carbon Monoxide - pharmacology</topic><topic>Carbon Monoxide - toxicity</topic><topic>Carbon Monoxide Poisoning</topic><topic>Cell Death</topic><topic>Heme Oxygenase (Decyclizing) - metabolism</topic><topic>Humans</topic><topic>Hyperbaric Oxygenation</topic><topic>Inflammation - pathology</topic><topic>Models, Biological</topic><topic>Neurons - drug effects</topic><topic>Neurons - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mannaioni, P F</creatorcontrib><creatorcontrib>Vannacci, A</creatorcontrib><creatorcontrib>Masini, E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mannaioni, P F</au><au>Vannacci, A</au><au>Masini, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity</atitle><jtitle>Inflammation research</jtitle><addtitle>Inflamm Res</addtitle><date>2006-07</date><risdate>2006</risdate><volume>55</volume><issue>7</issue><spage>261</spage><epage>273</epage><pages>261-273</pages><issn>1023-3830</issn><eissn>1420-908X</eissn><abstract>The double origin of carbon monoxide (CO) as an atmospheric pollutant or as an endogenous gaseous modulator of many pathophysiological processes prompted us to review some aspects of the bad side and of the good side of coin among the pleiotropic effects of CO. On the bad side of the coin, we focus on the interval form in acute CO poisoning, discussing experimental evidence suggesting that the delayed neuropathology after CO poisoning is a free radical-driven event. In this context, we challenge the mandatory place of hyperbaric oxygen therapy (HBO) in CO poisoning as a possible summation of oxy-radicals generated by HBO and the free radical cascade set in motion during the reoxygenation phase of acute CO-poisoning. We also discuss an opposing view, which provides evidence suggesting that HBO therapy actually decreases the load of free radicals in acute CO-poisoning and may be beneficial in preventing delayed neuropsychiatric sequelae.On the good side of the coin, we briefly outline the endogenous generation of CO and the leading role of heme-oxygenases (HO) in relation to the place of CO in biology and medicine. The main focus of this section is on the growing literature on CO and inflammation. Here we report on in-vitro and in-vivo studies on the modulation afforded by exogenously administered/endogenously produced CO in a variety of experimental and clinical settings of inflammation. Our recent studies on experimental models of allergic inflammation are also discussed, and the CO-releasing molecules envisaged as potential anti-inflammatory drugs suitable for clinical use.</abstract><cop>Switzerland</cop><pub>Springer Nature B.V</pub><pmid>16955388</pmid><doi>10.1007/s00011-006-0084-y</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1023-3830 |
ispartof | Inflammation research, 2006-07, Vol.55 (7), p.261-273 |
issn | 1023-3830 1420-908X |
language | eng |
recordid | cdi_proquest_journals_216240444 |
source | MEDLINE; SpringerNature Journals |
subjects | Animals Anti-Inflammatory Agents - pharmacology Carbon Monoxide - pharmacology Carbon Monoxide - toxicity Carbon Monoxide Poisoning Cell Death Heme Oxygenase (Decyclizing) - metabolism Humans Hyperbaric Oxygenation Inflammation - pathology Models, Biological Neurons - drug effects Neurons - pathology |
title | Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A24%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbon%20monoxide:%20the%20bad%20and%20the%20good%20side%20of%20the%20coin,%20from%20neuronal%20death%20to%20anti-inflammatory%20activity&rft.jtitle=Inflammation%20research&rft.au=Mannaioni,%20P%20F&rft.date=2006-07&rft.volume=55&rft.issue=7&rft.spage=261&rft.epage=273&rft.pages=261-273&rft.issn=1023-3830&rft.eissn=1420-908X&rft_id=info:doi/10.1007/s00011-006-0084-y&rft_dat=%3Cproquest_cross%3E1124432021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216240444&rft_id=info:pmid/16955388&rfr_iscdi=true |